• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成骨细胞谱系中Rb和p53失活诱导的转移性骨肉瘤。

Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage.

作者信息

Berman Seth D, Calo Eliezer, Landman Allison S, Danielian Paul S, Miller Emily S, West Julie C, Fonhoue Borel Djouedjong, Caron Alicia, Bronson Roderick, Bouxsein Mary L, Mukherjee Siddhartha, Lees Jacqueline A

机构信息

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

出版信息

Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11851-6. doi: 10.1073/pnas.0805462105. Epub 2008 Aug 12.

DOI:10.1073/pnas.0805462105
PMID:18697945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2575280/
Abstract

Mutation of the RB-1 and p53 tumor suppressors is associated with the development of human osteosarcoma. With the goal of generating a mouse model of this disease, we used conditional and transgenic mouse strains to inactivate Rb and/or p53 specifically in osteoblast precursors. The resulting Rb;p53 double mutant (DKO) animals are viable but develop early onset osteosarcomas with complete penetrance. These tumors display many of the characteristics of human osteosarcomas, including being highly metastatic. We established cell lines from the DKO osteosarcomas to further investigate their properties. These immortalized cell lines are highly proliferative and they retain their tumorigenic potential, as judged by their ability to form metastatic tumors in immunocompromised mice. Moreover, they can be induced to differentiate and, depending on the inductive signal, will adopt either the osteogenic or adipogenic fate. Consistent with this multipotency, a significant portion of these tumor cells express Sca-1, a marker that is typically associated with stem cells/uncommitted progenitors. By assaying sorted cells in transplant assays, we demonstrate that the tumorigenicity of the osteosarcoma cell lines correlates with the presence of the Sca-1 marker. Finally, we show that loss of Rb and p53 in Sca-1-positive mesenchymal stem/progenitor cells is sufficient to yield transformed cells that can initiate osteosarcoma formation in vivo.

摘要

RB-1和p53肿瘤抑制因子的突变与人类骨肉瘤的发生有关。为了建立这种疾病的小鼠模型,我们使用条件性和转基因小鼠品系,在成骨细胞前体细胞中特异性地使Rb和/或p53失活。由此产生的Rb;p53双突变(DKO)动物是存活的,但会发生具有完全外显率的早发性骨肉瘤。这些肿瘤表现出许多人类骨肉瘤的特征,包括高度转移性。我们从DKO骨肉瘤中建立了细胞系,以进一步研究它们的特性。这些永生化细胞系具有高度增殖性,并且保留了它们的致瘤潜力,这可以通过它们在免疫缺陷小鼠中形成转移性肿瘤的能力来判断。此外,它们可以被诱导分化,并且根据诱导信号,会选择成骨或成脂命运。与这种多能性一致,这些肿瘤细胞中有很大一部分表达Sca-1,这是一种通常与干细胞/未分化祖细胞相关的标志物。通过在移植实验中检测分选的细胞,我们证明骨肉瘤细胞系的致瘤性与Sca-1标志物的存在相关。最后,我们表明Sca-1阳性间充质干/祖细胞中Rb和p53的缺失足以产生能够在体内引发骨肉瘤形成的转化细胞。

相似文献

1
Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage.成骨细胞谱系中Rb和p53失活诱导的转移性骨肉瘤。
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11851-6. doi: 10.1073/pnas.0805462105. Epub 2008 Aug 12.
2
The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse.成骨细胞分化对小鼠骨肉瘤发生的影响。
Oncogene. 2015 Aug 6;34(32):4278-84. doi: 10.1038/onc.2014.354. Epub 2014 Oct 27.
3
Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.成骨细胞分化和骨骼发育受Mdm2-p53信号通路调控。
J Cell Biol. 2006 Mar 13;172(6):909-21. doi: 10.1083/jcb.200508130.
4
Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.在人骨髓间充质干细胞中,通过 Rb 失活和 c-Myc 过表达的组合生成骨肉瘤。
Stem Cells Transl Med. 2017 Feb;6(2):512-526. doi: 10.5966/sctm.2015-0226. Epub 2016 Sep 7.
5
mTORC1 maintains the tumorigenicity of SSEA-4(+) high-grade osteosarcoma.mTORC1维持SSEA-4(+)高级别骨肉瘤的致瘤性。
Sci Rep. 2015 Apr 8;5:9604. doi: 10.1038/srep09604.
6
The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.p53-Rb 缺陷型骨髓间充质干细胞的分化阶段赋予体内肉瘤发展的表型。
Oncogene. 2013 Oct 10;32(41):4970-80. doi: 10.1038/onc.2012.507. Epub 2012 Dec 10.
7
Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).Runx2、p53和pRB状态作为一种新的化疗前骨肉瘤细胞系(OS1)中成骨细胞生长与分化失调的诊断参数。
J Cell Physiol. 2009 Dec;221(3):778-88. doi: 10.1002/jcp.21921.
8
Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.骨环境对于转化的间充质干细胞发展成骨肉瘤至关重要。
Stem Cells. 2014 May;32(5):1136-48. doi: 10.1002/stem.1647.
9
Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas.Sox2 维持骨肉瘤肿瘤起始细胞的自我更新。
Oncogene. 2012 May 3;31(18):2270-82. doi: 10.1038/onc.2011.405. Epub 2011 Sep 19.
10
The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.MET 癌基因通过靶向定向成骨祖细胞将人原代骨源性细胞转化为成骨肉瘤。
J Bone Miner Res. 2012 Jun;27(6):1322-34. doi: 10.1002/jbmr.1578.

引用本文的文献

1
Clinical insights into circulating free-DNA in patients with bone sarcomas and ewing sarcoma.骨肉瘤和尤因肉瘤患者循环游离DNA的临床见解。
Clinics (Sao Paulo). 2025 Apr 26;80:100661. doi: 10.1016/j.clinsp.2025.100661. eCollection 2025.
2
Clinicopathological correlations and prognostic insights in osteosarcoma: a retrospective analysis.骨肉瘤的临床病理相关性及预后分析:一项回顾性研究
Rom J Morphol Embryol. 2024 Oct-Dec;65(4):723-736. doi: 10.47162/RJME.65.4.19.
3
Loss Enhances Disease Progression in a Murine Model of Osteosarcoma.在骨肉瘤小鼠模型中,损耗会加速疾病进展。
Cancers (Basel). 2024 Jul 31;16(15):2725. doi: 10.3390/cancers16152725.
4
Myc upregulates Ggct, γ-glutamylcyclotransferase to promote development of p53-deficient osteosarcoma.Myc 上调 Ggct,γ-谷氨酰环转移酶,促进 p53 缺失型骨肉瘤的发展。
Cancer Sci. 2024 Sep;115(9):2961-2971. doi: 10.1111/cas.16255. Epub 2024 Jun 26.
5
Collagen type X expression and chondrocyte hypertrophic differentiation during OA and OS development.骨关节炎(OA)和骨肉瘤(OS)发展过程中X型胶原蛋白的表达及软骨细胞肥大分化
Am J Cancer Res. 2024 Apr 15;14(4):1784-1801. doi: 10.62347/JWGW7377. eCollection 2024.
6
PRRX1-TOP2A interaction is a malignancy-promoting factor in human malignant peripheral nerve sheath tumours.PRRX1-TOP2A 相互作用是促进人类恶性外周神经鞘瘤恶性进展的因素。
Br J Cancer. 2024 May;130(9):1493-1504. doi: 10.1038/s41416-024-02632-8. Epub 2024 Mar 6.
7
WWOX promotes osteosarcoma development via upregulation of Myc.WWOX 通过上调 Myc 促进骨肉瘤的发展。
Cell Death Dis. 2024 Jan 5;15(1):13. doi: 10.1038/s41419-023-06378-8.
8
Research trends and hotspots in the immune microenvironment related to osteosarcoma and tumor cell aging: a bibliometric and visualization study.骨肿瘤免疫微环境与肿瘤细胞衰老相关的研究趋势和热点:基于文献计量学和可视化的研究
Front Endocrinol (Lausanne). 2023 Nov 8;14:1289319. doi: 10.3389/fendo.2023.1289319. eCollection 2023.
9
Osteosarcoma in Pediatric and Adult Populations: Are Adults Just Big Kids?儿童和成人人群中的骨肉瘤:成人只是大孩子吗?
Cancers (Basel). 2023 Oct 19;15(20):5044. doi: 10.3390/cancers15205044.
10
Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype.配体依赖性 hedgehog 信号通路维持未分化的、恶性骨肉瘤表型。
Oncogene. 2023 Nov;42(47):3529-3541. doi: 10.1038/s41388-023-02864-7. Epub 2023 Oct 16.

本文引用的文献

1
The retinoblastoma protein tumor suppressor is important for appropriate osteoblast differentiation and bone development.视网膜母细胞瘤蛋白肿瘤抑制因子对于成骨细胞的正常分化和骨骼发育至关重要。
Mol Cancer Res. 2008 Sep;6(9):1440-51. doi: 10.1158/1541-7786.MCR-08-0176.
2
Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice.体内对干细胞/祖细胞群进行药理学靶向与小鼠骨再生增强相关。
J Clin Invest. 2008 Feb;118(2):491-504. doi: 10.1172/JCI33102.
3
A review of clinical and molecular prognostic factors in osteosarcoma.骨肉瘤临床及分子预后因素综述。
J Cancer Res Clin Oncol. 2008 Mar;134(3):281-97. doi: 10.1007/s00432-007-0330-x. Epub 2007 Oct 27.
4
Age-related changes in trabecular architecture differ in female and male C57BL/6J mice.雌性和雄性C57BL/6J小鼠小梁结构的年龄相关变化存在差异。
J Bone Miner Res. 2007 Aug;22(8):1197-207. doi: 10.1359/jbmr.070507.
5
Mesenchymal stem cell features of Ewing tumors.尤因肉瘤的间充质干细胞特征
Cancer Cell. 2007 May;11(5):421-9. doi: 10.1016/j.ccr.2007.02.027.
6
Molecular pathogenesis of osteosarcoma.骨肉瘤的分子发病机制
DNA Cell Biol. 2007 Jan;26(1):1-18. doi: 10.1089/dna.2006.0505.
7
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.由MLL-AF9引发的从定向祖细胞向白血病干细胞的转变。
Nature. 2006 Aug 17;442(7104):818-22. doi: 10.1038/nature04980. Epub 2006 Jul 16.
8
Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors.刺猬信号通路和经典Wnt信号通路在成骨细胞祖细胞的特化、分化和维持中的不同作用。
Development. 2006 Aug;133(16):3231-44. doi: 10.1242/dev.02480. Epub 2006 Jul 19.
9
Absence of the p53 tumor suppressor gene promotes osteogenesis in mesenchymal stem cells.p53肿瘤抑制基因的缺失促进间充质干细胞的成骨作用。
J Pediatr Surg. 2006 Apr;41(4):624-32; discussion 624-32. doi: 10.1016/j.jpedsurg.2005.12.001.
10
Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.成骨细胞分化和骨骼发育受Mdm2-p53信号通路调控。
J Cell Biol. 2006 Mar 13;172(6):909-21. doi: 10.1083/jcb.200508130.